Ceramides as Biomarkers of Cardiovascular Diseases and Heart Failure [0.03%]
ceramide：心血管疾病和心力衰竭的生物标志物
Silvio N Augusto Jr,Abhilash Suresh,W H Wilson Tang
Silvio N Augusto Jr
Purpose of review: Ceramides are lipid species that play several physiological roles in the body, including stress response, inflammation, and apoptosis, and their involvement in lipid metabolism and energy production ma...
Obesity, Metabolic Syndrome, and Obesity Paradox in Heart Failure: A Critical Evaluation [0.03%]
心力衰竭中的肥胖、代谢综合征和肥胖悖论的再评价
Vince J Catalfamo,Austin W Tutor,Adrienne Koos et al.
Vince J Catalfamo et al.
Purpose of review: Since the turn of the millennium, obesity has been on the rise worldwide, and particularly so throughout the United States. Even more concerning is the rate at which persons with severe obesity continue...
Revisiting Biomarkers of Cardiac Allograft Vasculopathy: Addressing the Achilles Heel of Heart Transplantation [0.03%]
心脏移植供体血管病的生物标志物再评价——解决心脏移植的“阿喀琉斯之踵”
Patrick E O&#x;Hara,Ananya Gorrai,Maryjane Farr et al.
Patrick E O&#x;Hara et al.
Nearly half of heart transplant recipients will be diagnosed with cardiac allograft vasculopathy (CAV) within five years after transplantation. Advanced CAV can lead to worsening heart failure as well as arrhythmias and sudden cardiac death...
Genetic Biomarkers in Heart Failure: From Gene Panels to Polygenic Risk Scores [0.03%]
心力衰竭的遗传生物标志物：从基因检测板到多基因风险评分
Marta Figueiral,Alessia Paldino,Luca Fazzini et al.
Marta Figueiral et al.
Purpose of review: This review aims to provide a comprehensive overview of the current understanding of genetic markers associated with heart failure (HF) and its underlying causative diseases, such as cardiomyopathies. I...
Emerging Biomarkers in Cardiac Sarcoidosis and Other Inflammatory Cardiomyopathies [0.03%]
心脏淋巴瘤和其他炎症性心肌病的新兴生物标志物
Joseph El Roumi,Ziad Taimeh
Joseph El Roumi
Purpose of review: Cardiac sarcoidosis and other inflammatory cardiomyopathies are disorders causing cardiac inflammation and leading to heart failure, arrythmias and cardiac arrest. Diagnosis of these entities remains ch...
Katharina Seuthe,Felix Simon Ruben Picard,Holger Winkels et al.
Katharina Seuthe et al.
Purpose of review: The co-occurrence of heart failure (HF) and cancer represents a complex and multifaceted medical challenge. Patients with prevalent cardiovascular disease (CVD), particularly HF, exhibit an increased ri...
Alison Brann,Sean Selko,Ethan Krauspe et al.
Alison Brann et al.
Purpose of review: The purpose of this review is to describe the evidence behind various blood and imaging-based biomarkers that can improve the identification of congestion when not clearly evident on routine examination...
Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population [0.03%]
筛查心脏病：检测一般人群发病风险的生物标志物
Leah B Kosyakovsky,Rudolf A de Boer,Jennifer E Ho
Leah B Kosyakovsky
Purpose of review: Heart failure (HF) represents a growing global burden of morbidity and mortality. Identifying individuals at risk for HF development is increasingly important, particularly given the advent of disease-m...
Alexis Zambrano Zambrano,Hector Del Río Zanatta,Andrea González Espinoza et al.
Alexis Zambrano Zambrano et al.
Purpose of review: This review focuses on the association between RA and heart failure, highlighting the role of inflammation and the prevalence of heart failure with preserved ejection fraction (HFpEF) in this population...
Troponin Elevation in Asymptomatic Cancer Patients: Unveiling Connections and Clinical Implications [0.03%]
无症状癌症患者的肌钙蛋白升高：揭示关联及临床意义
Sebastian W Romann,Evangelos Giannitsis,Norbert Frey et al.
Sebastian W Romann et al.
Purpose of the review: Elevated troponin levels are well established e.g., for the diagnosis of suspected acute coronary syndrome in symptomatic patients. In contrast, troponin elevations in asymptomatic cancer patients e...